All Insight, Analysis and Views

ViewPoints: Sarepta benefits from battles already won with Amondys 45

Ref: ViewPoints Desk

Tags: ViewPoints Sarepta Therapeutics Pfizer Solid Biosciences Duchenne Muscular Dystrophy FDA Marketing & Sales Medical Affairs Regulatory Affairs AMONDYS 45 Exondys 51 Vyondys 53

Physician Views Preview: Pulmonologists assess new tezepelumab data

Ref: Physician Views Desk

Tags: Physician Views Poll Results Amgen AstraZeneca Roche Teva GSK Asthma Clinical Research (R&D) Medical Affairs tezepelumab

Survey: Physicians still engaging half as frequently with drug sales reps versus a year ago

Ref: Physician Views Desk

Tags: Physician Views Poll Results COVID-19 Marketing & Sales Medical Affairs

ViewPoints: Three’s a welcome crowd – J&J offers more than just one more COVID-19 vaccine

Ref: ViewPoints Desk

Tags: ViewPoints J&J Pfizer BioNTech Moderna AstraZeneca COVID-19 FDA Marketing & Sales Medical Affairs Regulatory Affairs JNJ-78436735

Friday Five – The pharma week in review (26 February 2021)

Ref: Friday Five Desk

Tags: Friday Five Clinical Research (R&D) Marketing & Sales Medical Affairs Mergers & Acquisitions Regulatory Affairs

ViewPoints: Merck signs up for novel approach to treating autoimmune diseases

Ref: ViewPoints Desk

Tags: ViewPoints Merck & Co. Pandion Therapeutics Mergers & Acquisitions PT101

Physician Views results – Cardiologists likely to be cautious towards new Entresto label

Ref: Physician Views Desk

Tags: Physician Views Poll Results Novartis Congestive Heart Failure Medical Affairs Regulatory Affairs Entresto

FirstImpact results: Survey suggests US docs could view Xeljanz safety flags as class-impacting

Ref: Physician Views Desk

Tags: Physician Views Poll Results Pfizer Lilly AbbVie Galapagos Arthritis Clinical Research (R&D) Marketing & Sales Medical Affairs Xeljanz Olumiant Rinvoq Jyseleca

ViewPoints: AbbVie keeps doing what it can to build Rinvoq’s brand

Ref: ViewPoints Desk

Tags: ViewPoints AbbVie Pfizer Lilly Galapagos Gilead Arthritis IBD FDA Marketing & Sales Medical Affairs Regulatory Affairs Rinvoq Olumiant Xeljanz Jyseleca

Physician Views preview: Entresto gets expanded approval

Ref: Physician Views Desk

Tags: Physician Views Novartis Congestive Heart Failure Marketing & Sales Medical Affairs Regulatory Affairs Entresto